Akebia Therapeutics, Inc.AKBANASDAQ
Loading
Asset Growth AcceleratingAccelerating
Percentile Rank69
Studio
Year-over-Year Change

Year-over-year total asset growth rate

Latest
70.65%
↑ 188% vs avg
Percentile
P69
Within normal range
Streak
3 yr
Consecutive growthAccelerating
Average
24.51%
Historical baseline
PeriodValue
202570.65%
2024-8.70%
2023-32.12%
2022-32.74%
2021-17.82%
2020-16.48%
2019-22.61%
2018173.59%
201721.33%
2016110.03%